skip to Main Content

How Diabetes Drug Metformin Inhibits Progression of Pancreatic Cancer

Newsfeed image, light gray text on dark gray background
Massachusetts General Hospital (MGH) investigators may have uncovered a novel mechanism behind the ability of the diabetes drug metformin to inhibit the progression of pancreatic cancer.

In their report that has been published in the open access journal PLOS One, the research team describes finding that metformin decreases the inflammation and fibrosis characteristic of the most common form of pancreatic cancer. Read more . . .

Back To Top